Trials assessing the impact of albumin in patients with cirrhosis and SBP were considered for inclusion. Ascitic fluid polymorphonuclear cell counts of 250/mm3 in three trials or 250/mm3 in one trial were used to diagnose SBP in the absence of any indication of secondary peritonitis. The gene discussed is ALB; the disease is Cirrhosis.